Clinical trial
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies…
NCT00117117 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00117117 |
|---|---|
| Title | A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® |
| Official title | A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Aranesp |
| Enrollment | 2,423 |
| Start date | Sep 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Jul 4, 2005 |
| Last update posted | Mar 25, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: